• Subscribe
  • Advertise
  • Contact Us
June 15, 2025
Pharma News HQ


  • Home
  • News
  • Clinical Trials
  • Drug Development
  • Manufacturing
  • Packaging and Labeling
  • Cold Chain
  • Diseases
  • Technology
  • Press Feed
    • Articles
    • Press Releases
  • Events
Top Headlines
  • [ February 14, 2023 ] Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues Manufacturing
  • [ February 14, 2023 ] Genenta Science signs manufacturing deal with AGC Biologics Manufacturing
  • [ February 14, 2023 ] Vial and Egnyte announce partnership for eTMF solution integration Clinical Trials
  • [ February 14, 2023 ] SOPHiA GENETICS and AstraZeneca partner for oncology drugs development Drug Development
  • [ February 14, 2023 ] FDA suggests ways to curb constraints with rare disease gene therapy trials Clinical Trials
Home2018January

Month: January 2018

Diseases

NHS plans to be first to eliminate hepatitis C

January 31, 2018 Pharma News HQ 0

It is hoped that the next round of procurement, which launches in February and is to be the single largest medicines procurement ever done by the NHS, will see new agreements drawn up with drug […]

News

Wellcome announces new efforts to survey global antmicrobial resistance

January 31, 2018 Pharma News HQ 0

Wellcome has launched a new initiative to help improve surveillance of global drug-resistant infections. The Surveillance and Epidemiology of Drug-resistant Infections Consortium (SEDRIC), which launched on 30 January 2018, aims to help countries track the […]

Clinical Trials

Interim publications of randomized trials make news but may not be ready for prime time

January 31, 2018 Pharma News HQ 0

Early results from randomized trials are sometimes published before the trial is completed. The results of such interim publications may generate a great deal of interest in the medical community because the findings often hold […]

Cold Chain

Boots now selling cheaper morning after pill at all stores

January 31, 2018 Pharma News HQ 0

A cheaper generic emergency hormonal contraceptive (EHC) is now available at all UK branches of Boots — three months later than the company originally promised. Boots attributed the delay to a “manufacturing issue” which created […]

Diseases

Blood vessel-on-a-chips show anti-cancer drug effects in human cells

January 31, 2018 Pharma News HQ 0

Researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology for the study of blood vessel formation and drugs targeting this event. The technology recreates […]

Posts pagination

1 2 … 32 »



















  • Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

    February 14, 2023 0
  • Genenta Science signs manufacturing deal with AGC Biologics

    February 14, 2023 0
  • Vial and Egnyte announce partnership for eTMF solution integration

    February 14, 2023 0
  • SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

    February 14, 2023 0
  • FDA suggests ways to curb constraints with rare disease gene therapy trials

    February 14, 2023 0
Pharma News HQ

Pharma News HQ, the journal dedicated to the pharmaceutical and biopharmaceutical contract services. With regular sections on contract manufacturing, contract research, contract packaging, formulation/development services, contract analytical testing, APIs, stability testing, clinical research and other areas, we bring the most complete coverage of trends and issues in the industry. Pharmanewshq.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production.

 

About Us

 

Subscribe

 

Contact US

Latest Post
  • Sun Pharma recalls over 34k bottles of generic drug in US due to manufacturing issues

    February 14, 2023 0
  • Genenta Science signs manufacturing deal with AGC Biologics

    February 14, 2023 0
  • Vial and Egnyte announce partnership for eTMF solution integration

    February 14, 2023 0
  • SOPHiA GENETICS and AstraZeneca partner for oncology drugs development

    February 14, 2023 0
  • FDA suggests ways to curb constraints with rare disease gene therapy trials

    February 14, 2023 0